免疫检查点抑制剂治疗转移性黑色素瘤患者的生精功能损害与免疫检查点抑制剂的相关性。
Association of Impaired Spermatogenesis With the Use of Immune Checkpoint Inhibitors in Patients With Metastatic Melanoma.
机构信息
Scott Department of Urology, Baylor College of Medicine, Houston, Texas.
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
出版信息
JAMA Oncol. 2020 Aug 1;6(8):1297-1299. doi: 10.1001/jamaoncol.2020.1641.
Abstract
This cohort study examines the potential association of the use of immune checkpoint inhibitors with testicular histopathologic conditions.
摘要
本队列研究探讨了免疫检查点抑制剂的使用与睾丸组织病理状况之间的潜在关联。
相似文献
1
Association of Impaired Spermatogenesis With the Use of Immune Checkpoint Inhibitors in Patients With Metastatic Melanoma.免疫检查点抑制剂治疗转移性黑色素瘤患者的生精功能损害与免疫检查点抑制剂的相关性。
JAMA Oncol. 2020 Aug 1;6(8):1297-1299. doi: 10.1001/jamaoncol.2020.1641.
2
Immune checkpoint inhibitors-associated risk of immune-related hypothyroidism in older patients with advanced melanoma: a real-world analysis of US SEER-Medicare data.免疫检查点抑制剂相关的免疫相关性甲状腺功能减退风险在老年晚期黑色素瘤患者中：来自美国 SEER-Medicare 数据的真实世界分析。
Expert Opin Drug Saf. 2021 Apr;20(4):489-497. doi: 10.1080/14740338.2021.1877272. Epub 2021 Jan 25.
3
Vogt-Koyanagi-Harada-like syndrome induced by immune checkpoint inhibitors in a patient with melanoma.免疫检查点抑制剂诱发黑色素瘤患者出现类伏格特-小柳-原田综合征
Clin Exp Dermatol. 2020 Oct;45(7):908-911. doi: 10.1111/ced.14282. Epub 2020 Jul 5.
4
Side effect management during immune checkpoint blockade using CTLA-4 and PD-1 antibodies for metastatic melanoma - an update.免疫检查点阻断治疗转移性黑色素瘤中 CTLA-4 和 PD-1 抗体的副作用管理 - 最新进展。
J Dtsch Dermatol Ges. 2020 Jun;18(6):582-609. doi: 10.1111/ddg.14128. Epub 2020 Jun 3.
5
A case of Schönlein-Henoch purpura induced by immune checkpoint inhibitor in a patient with metastatic melanoma.1例转移性黑色素瘤患者因免疫检查点抑制剂诱发的过敏性紫癜。
Eur J Cancer. 2020 Nov;139:169-172. doi: 10.1016/j.ejca.2020.08.005. Epub 2020 Sep 29.
6
Encephalitis induced by immune checkpoint inhibitors in metastatic melanoma: a monocentric retrospective study.免疫检查点抑制剂诱发的转移性黑色素瘤脑炎：一项单中心回顾性研究
J Eur Acad Dermatol Venereol. 2019 Dec;33(12):e440-e443. doi: 10.1111/jdv.15756. Epub 2019 Jul 26.
7
Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series report.免疫检查点抑制剂治疗转移性黑色素瘤患者致急性肾损伤的组织学诊断：一项回顾性病例系列报告。
BMC Nephrol. 2020 Sep 7;21(1):391. doi: 10.1186/s12882-020-02044-9.
8
Immune-related pancytopenia caused by nivolumab and ipilimumab combination therapy for unresectable melanoma of unknown primary.纳武单抗和伊匹单抗联合治疗未知原发灶不可切除黑色素瘤引起的免疫相关性全血细胞减少症。
J Dermatol. 2020 Jun;47(6):e237-e239. doi: 10.1111/1346-8138.15341. Epub 2020 Apr 9.
9
Prevalence of dermatological toxicities in patients with melanoma undergoing immunotherapy: Systematic review and meta-analysis.接受免疫治疗的黑色素瘤患者的皮肤病学毒性发生率：系统评价和荟萃分析。
PLoS One. 2021 Aug 6;16(8):e0255716. doi: 10.1371/journal.pone.0255716. eCollection 2021.
10
Haemophagocytic lymphohistiocytosis associated with immune checkpoint inhibitors: a descriptive case study and literature review.免疫检查点抑制剂相关噬血细胞性淋巴组织细胞增生症：一项描述性病例研究及文献综述
Br J Haematol. 2020 Jun;189(5):985-992. doi: 10.1111/bjh.16630. Epub 2020 Apr 3.
引用本文的文献
1
Gonadotoxicity of immunotherapy and targeted agents in patients with cancer and impact on subsequent pregnancies.癌症患者免疫疗法和靶向药物的性腺毒性及其对后续妊娠的影响。
Hum Reprod. 2025 Aug 1;40(8):1452-1466. doi: 10.1093/humrep/deaf096.
2
Anti-CTLA-and anti-PD-1 immune checkpoint inhibitor antibodies impair human sperm motility .抗细胞毒性T淋巴细胞相关蛋白4（CTLA）和抗程序性死亡受体1（PD-1）免疫检查点抑制剂抗体损害人类精子活力。
Front Pharmacol. 2025 Mar 31;16:1534975. doi: 10.3389/fphar.2025.1534975. eCollection 2025.
3
Resveratrol alleviates testicular toxicity induced by anti-PD-1 through regulating the NRF2-SLC7A11-GPX4 pathway.白藜芦醇通过调节NRF2-SLC7A11-GPX4通路减轻抗PD-1诱导的睾丸毒性。
Front Immunol. 2025 Mar 12;16:1529991. doi: 10.3389/fimmu.2025.1529991. eCollection 2025.
4
Pharmacovigilance analysis of immune checkpoint inhibitor-related reproductive adverse effects based on the FDA adverse event reporting system.基于美国食品药品监督管理局不良事件报告系统的免疫检查点抑制剂相关生殖不良反应的药物警戒分析
Sci Rep. 2025 Mar 5;15(1):7770. doi: 10.1038/s41598-025-91476-0.
5
Fertility Preservation in the Era of Immuno-Oncology: Lights and Shadows.免疫肿瘤学时代的生育力保存：光明与阴影
J Pers Med. 2024 Apr 19;14(4):431. doi: 10.3390/jpm14040431.
6
Immune Checkpoint Inhibitors and Male Fertility: Should Fertility Preservation Options Be Considered before Treatment?免疫检查点抑制剂与男性生育能力：治疗前是否应考虑生育力保存方案？
Cancers (Basel). 2024 Mar 17;16(6):1176. doi: 10.3390/cancers16061176.
7
Clinical and translational attributes of immune-related adverse events.免疫相关不良反应的临床和转化特征。
Nat Cancer. 2024 Apr;5(4):557-571. doi: 10.1038/s43018-024-00730-3. Epub 2024 Feb 15.
8
[Fertility and fertility preservation in men].[男性生育与生育力保存]
Dermatologie (Heidelb). 2023 Jul;74(7):490-495. doi: 10.1007/s00105-023-05167-w. Epub 2023 Jun 7.
9
The Impact of Systemic Oncological Treatments on the Fertility of Adolescents and Young Adults-A Systematic Review.全身肿瘤治疗对青少年和年轻成年人生育能力的影响——一项系统评价
Life (Basel). 2023 May 18;13(5):1209. doi: 10.3390/life13051209.
10
The Uncharted Landscape of Rare Endocrine Immune-Related Adverse Events.罕见内分泌免疫相关不良事件的未知领域
Cancers (Basel). 2023 Mar 28;15(7):2016. doi: 10.3390/cancers15072016.
本文引用的文献
1
Effect of a formal oncofertility program on fertility preservation rates-first year experience.一项正式的肿瘤生育力保存计划对生育力保存率的影响——首年经验
Transl Androl Urol. 2018 Jul;7(Suppl 3):S271-S275. doi: 10.21037/tau.2018.04.24.
2
Endocrine, Sexual Function, and Infertility Side Effects of Immune Checkpoint Inhibitor Therapy for Genitourinary Cancers.免疫检查点抑制剂治疗泌尿生殖系统癌症的内分泌、性功能及不孕副作用
Curr Urol Rep. 2018 Jul 3;19(9):68. doi: 10.1007/s11934-018-0819-7.
3
Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update.癌症患者的生育力保存：ASCO 临床实践指南更新。
J Clin Oncol. 2018 Jul 1;36(19):1994-2001. doi: 10.1200/JCO.2018.78.1914. Epub 2018 Apr 5.
4
Prevalence and Predictors of Sperm Banking in Adolescents Newly Diagnosed With Cancer: Examination of Adolescent, Parent, and Provider Factors Influencing Fertility Preservation Outcomes.新诊断为癌症的青少年精子库的患病率及预测因素：对影响生育力保存结果的青少年、父母及医疗服务提供者因素的研究。
J Clin Oncol. 2017 Dec 1;35(34):3830-3836. doi: 10.1200/JCO.2016.70.4767. Epub 2017 Oct 4.
5
Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial.纳武利尤单抗与伊匹木单抗联合用药对比伊匹木单抗单药治疗晚期黑色素瘤患者：一项多中心、随机、对照、2期试验的2年总生存结果
Lancet Oncol. 2016 Nov;17(11):1558-1568. doi: 10.1016/S1470-2045(16)30366-7. Epub 2016 Sep 9.
6
Testicular biopsy score count--a method for registration of spermatogenesis in human testes: normal values and results in 335 hypogonadal males.睾丸活检评分计数——一种记录人类睾丸生精功能的方法：335例性腺功能减退男性的正常值及结果
Hormones. 1970;1(1):2-25. doi: 10.1159/000178170.
Zotero 插件